Luly Jay R.
Enanta Pharmaceuticals Inc · President and CEO
Luly Jay R. is listed in public filings as director, officer: President and CEO. This Luly Jay R. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enanta Pharmaceuticals Inc (ENTA). Investors use Luly Jay R.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --862.8k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable4.8k shares | -- | -- | |
| --878k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable15.2k shares | -- | -- | |
| $12M871.9k shares | Grant / ExerciseFeb 12, 2026 | $87.7K6.2k shares | $14.25 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $12M858k shares | SellDec 5, 2025 | $67.5K4.7k shares | $14.23 | -- | |
| $12M862.8k shares | Grant / ExerciseDec 1, 2025 | $26.6K1.9k shares | $14.12 | -- | |
| $4.2M310k shares | Grant / ExerciseNov 25, 2025 | $4.2M310k shares | $13.66 | -- | |
| $4.8M846.6k shares | BuyFeb 12, 2025 | $256.1K45k shares | $5.69 | -- | |
| --872.1k shares | Grant / ExerciseFeb 12, 2025 | Disclosure amount unavailable25.5k shares | -- | -- | |
| $4.8M864.7k shares | Grant / ExerciseFeb 12, 2025 | $41.8K7.5k shares | $5.59 | -- | |
| $6.5M801.6k shares | SellDec 6, 2024 | $41.4K5.1k shares | $8.06 | -- | |
| $6.9M806.8k shares | Grant / ExerciseDec 1, 2024 | $32.9K3.8k shares | $8.60 | -- | |
| $2.2M250k shares | Grant / ExerciseNov 27, 2024 | $2.2M250k shares | $8.83 | -- |